We&Win Diversification Co Ltd (4113) Fair Value & Analysis
Industrials · TW · Market cap 3.4B TWD
Risks
Fair value as of: Aug 19, 2026
From 3 valuation models · updated 5 days ago
Share price +0.7% over the past month.
Below-average quality, and trading another 13% above our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The model range is unusually wide (6.99 TWD to 18.85 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range 10.50 TWD – 64.90 TWD · fair‑value band 6.99 TWD – 18.85 TWD · the 14.85 TWD price screens above the 13.16 TWD fair value. Dashed = 300-day average. As of Aug 19, 2026.
Analysis
We&Win Diversification Co Ltd (4113) currently trades at 14.85 TWD, while our model-based Fair Value estimate is 13.16 TWD, implying the stock looks roughly 11.4% overvalued today. The Quality Score stands at 28/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 159M TWD. It earns a return on equity of -3.8%. Net debt stands at 9.7B TWD. Fundamentals as of Aug 19, 2026
Our scenario range runs from 6.99 TWD (bear case) to 18.85 TWD (bull case); at 14.85 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 44% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -46% fair-value upside, at -11%, 4113 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 3 models by family
Widest divergence: Dividend Discount (12.86 TWD) versus Asset-Based (12.37 TWD). Highest evidence: Gordon GGM (70).
Notify me when 4113 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 27 · Market factors (momentum, volatility) 34
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc.
Full company description
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
We&Win Diversification Co Ltd reported revenue of 610M TWD in FY2025 versus 1.4B TWD in FY2021, a compound −19.3%/yr. Reported net income was −100M TWD in FY2025.
4113 screens 11% overvalued. Compare with Quanta Services, Inc →
Peer Group
Engineering & Construction · 841 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Engineering & Construction median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Engineering & Construction stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Quanta Services, Inc PWR | $678.02 | $143.92 | -79% |
| Vinci SA DG | €119.95 | €185.62 | +55% |
| Comfort Systems USA, Inc FIX | $1,739 | $519.97 | -70% |
| Larsen & Toubro Limited LT | ₹4,072 | ₹2,196 | -46% |
| Ferrovial N.V FER | €57.28 | €19.17 | -67% |
| HOCHTIEF Aktiengesellschaft HOT | €427.60 | €203.87 | -52% |
| Samsung C&T Corporation 028260 | 357,500 KRW | 261,411 KRW | -27% |
| ACS, Actividades de Construcción y Servicios, S.A ACS | €110.70 | €75.04 | -32% |
| EMCOR Group EME | $833.40 | $549.47 | -34% |
| MasTec, Inc MTZ | $281.11 | $100.00 | -64% |
Compare We&Win Diversification Co Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is We&Win Diversification Co Ltd (4113) overvalued or undervalued?
What is the fair value of 4113?
What is the quality score of 4113?
What is the revenue of We&Win Diversification Co Ltd (4113)?
What is the net profit margin of 4113?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track We&Win Diversification Co Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.